CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 9, Pages 1358
Publisher
MDPI AG
Online
2019-09-12
DOI
10.3390/cancers11091358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients
- (2019) Friederike Christen et al. BLOOD
- Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment
- (2019) Christina Rautenberg et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?
- (2019) Musa Yilmaz et al. Blood Cancer Journal
- Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1
- (2019) Daniel Ernst et al. Blood Cancer Journal
- Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
- (2019) Maddalena Noviello et al. Nature Communications
- Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation
- (2019) Cristina Toffalori et al. NATURE MEDICINE
- Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia
- (2019) Nolwenn Lucas et al. LEUKEMIA
- Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies
- (2019) Matthew R. Collinson-Pautz et al. LEUKEMIA
- Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis
- (2019) Matthew A. Loberg et al. LEUKEMIA
- A novel method for detecting the cellular stemness state in normal and leukemic human hematopoietic cells can predict disease outcome and drug sensitivity
- (2019) Muhammad Yassin et al. LEUKEMIA
- Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML
- (2019) Peter Valent et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia
- (2019) Nana Arai et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Study on the prognostic value of aberrant antigen in patients with acute B lymphocytic leukemia
- (2019) Jun Liu et al. Clinical Lymphoma Myeloma & Leukemia
- Clonal hematopoiesis and preleukemia—Genetics, biology, and clinical implications
- (2019) Luise Hartmann et al. GENES CHROMOSOMES & CANCER
- Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group
- (2019) Olga K. Weinberg et al. MODERN PATHOLOGY
- Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
- (2019) Naveen Pemmaraju et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
- (2019) Sibylle Cocciardi et al. Nature Communications
- Clonal selection with Ras pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia
- (2019) Christine M. McMahon et al. Cancer Discovery
- Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
- (2019) Susanne Hofmann et al. Journal of Clinical Medicine
- Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
- (2019) Maria Rosaria Sapienza et al. Cancers
- Blastic Plasmacytoid Dendritic Cell Neoplasm–Current Insights
- (2019) Sangeetha Venugopal et al. Clinical Lymphoma Myeloma & Leukemia
- Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?
- (2019) Brian Ball et al. HAEMATOLOGICA
- Chimeric antigen receptor T-cell therapy for acute myeloid leukemia: how close to reality?
- (2019) Katherine D. Cummins et al. HAEMATOLOGICA
- Updates on CAR T-cell therapy in B-cell malignancies
- (2019) Elad Jacoby et al. IMMUNOLOGICAL REVIEWS
- DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistance
- (2019) Katsuhiro Togami et al. JOURNAL OF CLINICAL INVESTIGATION
- Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia
- (2018) Raphael Itzykson et al. BLOOD
- Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 Patients
- (2018) Philipp A. Greif et al. CLINICAL CANCER RESEARCH
- The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34 + CD123 + cells from acute myeloid leukemia / myelodysplastic syndrome patients and healthy donors
- (2018) Rajeswaran Mani et al. HAEMATOLOGICA
- Relapse of acute myeloid leukemia after allogeneic stem cell transplantation is associated with gain of WT1 alterations and high mutation load
- (2018) Sebastian Vosberg et al. HAEMATOLOGICA
- First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases
- (2018) Weili Sun et al. Journal of Hematology & Oncology
- Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia
- (2018) Jessica C. Petrov et al. LEUKEMIA
- Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
- (2018) S. Haubner et al. LEUKEMIA
- Molecular Minimal Residual Disease in Acute Myeloid Leukemia
- (2018) Mojca Jongen-Lavrencic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- A dual role for the N-terminal domain of the IL-3 receptor in cell signalling
- (2018) Sophie E. Broughton et al. Nature Communications
- The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34 + CD123 + cells from acute myeloid leukemia / myelodysplastic syndrome patients and healthy donors
- (2018) Rajeswaran Mani et al. HAEMATOLOGICA
- Relapse of acute myeloid leukemia after allogeneic stem cell transplantation is associated with gain of WT1 alterations and high mutation load
- (2018) Sebastian Vosberg et al. HAEMATOLOGICA
- The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia
- (2018) Nicolas Duployez et al. LEUKEMIA
- Survival outcomes of CD34+CD38−LSCs and their expression of CD123 in adult AML patients
- (2018) Asmaa M. Zahran et al. Oncotarget
- Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells
- (2018) Todd A. Braciak et al. OncoImmunology
- Mechanisms of immune escape after allogeneic hematopoietic cell transplantation
- (2018) Robert Zeiser et al. BLOOD
- CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping
- (2018) Anne E. Bras et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- CD123 expression patterns and selective targeting with a CD123-specific antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia
- (2018) Evgeniya Angelova et al. HAEMATOLOGICA
- Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation
- (2018) Mareike Frick et al. JOURNAL OF CLINICAL ONCOLOGY
- Histone deacetylase inhibitor targets CD123/CD47-positive cells and reverse chemoresistance phenotype in acute myeloid leukemia
- (2018) Bowen Yan et al. LEUKEMIA
- Single cell analysis of clonal architecture in acute myeloid leukaemia
- (2018) Nicola Potter et al. LEUKEMIA
- CD34+CD38− leukemic stem cell frequency to predict outcome in acute myeloid leukemia
- (2018) Wendelien Zeijlemaker et al. LEUKEMIA
- Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level
- (2018) Jiahao Chen et al. NATURE MEDICINE
- Immune Escape of Relapsed AML Cells after Allogeneic Transplantation
- (2018) Matthew J. Christopher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells
- (2017) Stephan Klöß et al. HUMAN GENE THERAPY
- Genomics of Acute Myeloid Leukemia Diagnosis and Pathways
- (2017) Lars Bullinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) Margaret R. O'Donnell et al. Journal of the National Comprehensive Cancer Network
- A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells
- (2017) A Ray et al. LEUKEMIA
- Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia
- (2017) Silvia Arcangeli et al. MOLECULAR THERAPY
- Tracing the origins of relapse in acute myeloid leukaemia to stem cells
- (2017) Liran I. Shlush et al. NATURE
- CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission
- (2017) L H Xie et al. Blood Cancer Journal
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
- (2016) Michael R. Grever et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
- (2016) Marco Ruella et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones
- (2016) Adhra Al-Mawali et al. Journal of Hematology & Oncology
- Dynamics of clonal evolution in myelodysplastic syndromes
- (2016) Hideki Makishima et al. NATURE GENETICS
- Assessment of Minimal Residual Disease in Standard-Risk AML
- (2016) Adam Ivey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform
- (2015) M. Al-Hussaini et al. BLOOD
- Hematopoietic stem cell transplantation for patients with AML in first complete remission
- (2015) J. J. Cornelissen et al. BLOOD
- Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells
- (2015) Elvira Pelosi et al. BLOOD CELLS MOLECULES AND DISEASES
- A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia
- (2015) D. F. Angelini et al. CLINICAL CANCER RESEARCH
- The βc receptor family – Structural insights and their functional implications
- (2015) Sophie E. Broughton et al. CYTOKINE
- Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice
- (2015) E. M. Lee et al. HAEMATOLOGICA
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates
- (2015) Gurunadh R. Chichili et al. Science Translational Medicine
- Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice
- (2015) E. M. Lee et al. HAEMATOLOGICA
- Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
- (2014) R. C. Lindsley et al. BLOOD
- Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients
- (2014) A. E. Frankel et al. BLOOD
- Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells
- (2014) S. Gill et al. BLOOD
- SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia
- (2014) Olga Frolova et al. BRITISH JOURNAL OF HAEMATOLOGY
- In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
- (2014) F. Angelot-Delettre et al. HAEMATOLOGICA
- Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC
- (2014) S J Busfield et al. LEUKEMIA
- Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo
- (2014) I Pizzitola et al. LEUKEMIA
- A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia
- (2014) Simon Z. He et al. LEUKEMIA & LYMPHOMA
- Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
- (2014) A Ehninger et al. Blood Cancer Journal
- Dual Mechanism of Interleukin-3 Receptor Blockade by an Anti-Cancer Antibody
- (2014) Sophie E. Broughton et al. Cell Reports
- T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
- (2013) A. Mardiros et al. BLOOD
- Monoclonal antibody targeting of IL-3 receptor with CSL362 effectively depletes CML progenitor and stem cells
- (2013) E. Nievergall et al. BLOOD
- Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor
- (2013) Sarah Tettamanti et al. BRITISH JOURNAL OF HAEMATOLOGY
- Signalling by the βc family of cytokines
- (2013) Timothy R. Hercus et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study
- (2013) L. Pagano et al. HAEMATOLOGICA
- Distinguishing hairy cell leukemia variant from hairy cell leukemia: Development and validation of diagnostic criteria
- (2013) Haipeng Shao et al. LEUKEMIA RESEARCH
- Flow cytometric quantification and immunophenotyping of leukemic stem cells in acute myeloid leukemia
- (2012) Keumrock Hwang et al. ANNALS OF HEMATOLOGY
- Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation
- (2012) D. Roos-Weil et al. BLOOD
- The Origin and Evolution of Mutations in Acute Myeloid Leukemia
- (2012) John S. Welch et al. CELL
- The GM-CSF receptor family: Mechanism of activation and implications for disease
- (2012) Timothy R. Hercus et al. GROWTH FACTORS
- The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling
- (2012) Sophie E. Broughton et al. IMMUNOLOGICAL REVIEWS
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Engineering a CD123xCD3 bispecific scFv immunofusion for the treatment of leukemia and elimination of leukemia stem cells
- (2012) S.-R. Kuo et al. PROTEIN ENGINEERING DESIGN & SELECTION
- CD123 Immunohistochemical Expression in Acute Myeloid Leukemia is Associated With Underlying FLT3-ITD and NPM1 Mutations
- (2012) Marian Rollins-Raval et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Characteristic CD103 and CD123 Expression Pattern Defines Hairy Cell Leukemia
- (2011) Girish Venkataraman et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Genome-wide Profiling in AML Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation
- (2011) Miguel Waterhouse et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- New markers for minimal residual disease detection in acute lymphoblastic leukemia
- (2011) E. Coustan-Smith et al. BLOOD
- Immunophenotypic features of acute myeloid leukaemia patients exhibiting high FLT3 expression not associated with mutations
- (2011) Roberta Riccioni et al. BRITISH JOURNAL OF HAEMATOLOGY
- High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study
- (2011) F. Vergez et al. HAEMATOLOGICA
- Flow cytometric analysis of CD123 is useful for immunophenotyping classical Hodgkin lymphoma
- (2010) Jonathan R. Fromm CYTOMETRY PART B-CLINICAL CYTOMETRY
- Distinct Expression Patterns of CD123 and CD34 on Normal Bone Marrow B-Cell Precursors (“Hematogones”) and B Lymphoblastic Leukemia Blasts
- (2009) Nagwa M. Hassanein et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
- (2009) Liqing Jin et al. Cell Stem Cell
- Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia
- (2009) M. Djokic et al. HAEMATOLOGICA
- Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor
- (2008) Roberta Riccioni et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia
- (2008) Arthur Frankel et al. LEUKEMIA & LYMPHOMA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started